Literature DB >> 15671102

Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene.

A Taillandier1, S-L Sallinen, I Brun-Heath, P De Mazancourt, J-L Serre, E Mornet.   

Abstract

Hypophosphatasia is an inherited disorder due to mutations in the bone alkaline phosphatase (ALPL) gene. We report here a patient with childhood hypophosphatasia diagnosed at 1.4 yr because of pectus excavatum, large anterior fontanel, rachitic skeletal changes, and low serum alkaline phosphatase. Sequencing of the ALPL gene produced evidence of two distinct missense mutations, E174K (c.571G>A), of maternal origin, and a de novo mutation, M45I (c.186G>C). The study of various microsatellite polymorphisms ruled out false paternity and therefore confirmed that M45I occurred de novo in the paternal germline or in the early development of the patient. Site-directed mutagenesis showed that M45I results in the absence of in vitro alkaline phosphatase activity, suggesting that the mutation is a severe allele. In conclusion, childhood hypophosphatasia in this patient is the result of compound heterozygosity for the moderate mutation E174K and a novel severe de novo mutation M45I.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671102     DOI: 10.1210/jc.2004-1456

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  A novel de novo heterozygous ALPL nonsense mutation associated with adult hypophosphatasia.

Authors:  L Martins; E L Dos Santos; A B de Almeida; R A Machado; A M Lyrio; B L Foster; K R Kantovitz; R D Coletta; F H Nociti
Journal:  Osteoporos Int       Date:  2020-06-23       Impact factor: 4.507

2.  Case report: multiple fractures in a patient with mutations of TWIST1 and TNSALP.

Authors:  Florian Barvencik; Matthias Gebauer; Thorsten Schinke; Michael Amling
Journal:  Clin Orthop Relat Res       Date:  2008-01-25       Impact factor: 4.176

Review 3.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

4.  Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis.

Authors:  Thomas Cruz; Marie Gleizes; Stéphane Balayssac; Etienne Mornet; Grégory Marsal; José Luis Millán; Myriam Malet-Martino; Lionel G Nowak; Véronique Gilard; Caroline Fonta
Journal:  J Neurochem       Date:  2017-03       Impact factor: 5.372

5.  Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation.

Authors:  Etienne Mornet; Agnès Taillandier; Christelle Domingues; Annika Dufour; Emmanuelle Benaloun; Nicole Lavaud; Fabienne Wallon; Nathalie Rousseau; Carole Charle; Mihelaiti Guberto; Christine Muti; Brigitte Simon-Bouy
Journal:  Eur J Hum Genet       Date:  2020-09-24       Impact factor: 4.246

6.  Pyridoxine-Responsive Seizures in Infantile Hypophosphatasia and a Novel Homozygous Mutation in ALPL Gene.

Authors:  Banu Güzel Nur; Gamze Çelmeli; Esra Manguoğlu; Erdoğan Soyucen; İffet Bircan; Ercan Mıhçı
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

7.  Orodental phenotype and genotype findings in all subtypes of hypophosphatasia.

Authors:  Amélie Reibel; Marie-Cécile Manière; François Clauss; Dominique Droz; Yves Alembik; Etienne Mornet; Agnès Bloch-Zupan
Journal:  Orphanet J Rare Dis       Date:  2009-02-21       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.